Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

1
Britain pulls back on security endorsement of China's Huawei: Sources

19h channelnewsasia
LONDON: Senior British security officials say they can give only limited assurances that Chinese firm Huawei's UK operations pose no threat to national security, downgrading their previous position, two people with knowledge of the matter told Reuters.
BT.A VOD VOD VODPF BTGOF DTEGF DTEGY BT

1
Britain says Huawei 'shortcomings' expose new telecom networks risks

19h channelnewsasia
LONDON: Technical and supply-chain issues with equipment made by Chinese firm Huawei have exposed Britain's telecom networks to new security risks, a government report said on Thursday.
BT.A VOD VOD VODPF BTGOF DTEGF DTEGY BT

6
Sinclair Broadcasting, Investors Bancorp Sink into Thursday’s 52-Week Low Club

23h 247wallst
July 19, 2018: Here are four stocks trading with heavy volume among 76 equities making new 52-week lows in Thursday’s session. On the NYSE advancers led decliners by about 1.4 to 1 and on the Nasdaq, advancers led decliners by about 1.27 to 1.
SBGL SBGL.WI VOD VOD VODPF ISBC TRBNW SBGI TRCO TRBAB

1
Exclusive: Britain says Huawei 'shortcomings' expose new telecom networks risks

2018-07-19 channelnewsasia
Senior British security officials say they can give only limited assurances that Chinese firm Huawei's UK operations pose no threat to national security, downgrading their previous position, two people with knowledge of the matter told Reuters.
BT.A VOD VOD VODPF BTGOF DTEGF DTEGY BT

1
Exclusive: Britain pulls back on security endorsement of China's Huawei: sources

2018-07-19 channelnewsasia
Senior British security officials say they can give only limited assurances that Chinese firm Huawei's UK operations pose no threat to national security, downgrading their previous position, two people with knowledge of the matter told Reuters.
BT.A VOD VOD VODPF BTGOF DTEGF DTEGY BT

1
Exclusive: Britain pulls back on security endorsement of China's Huawei - sources

2018-07-19 channelnewsasia
Senior British security officials say they can give only limited assurances that Chinese firm Huawei's UK operations pose no threat to national security, downgrading their previous position, two people with knowledge of the matter told Reuters.
BT.A VOD VOD VODPF BTGOF DTEGF DTEGY BT

1
Exclusive: Britain pulls back on security endorsement of China's Huawei - sources

2018-07-19 reuters
LONDON (Reuters) - Senior British security officials say they can give only limited assurances that Chinese firm Huawei’s UK operations pose no threat to national security, downgrading their previous position, two people with knowledge of the matter told Reuters.
BT.A VOD VOD VODPF BTGOF DTEGF DTEGY BT

15
Aveo Pharmaceuticals, Vodafone Pile into Wednesday’s 52-Week Low Club

2018-07-18 247wallst
July 18, 2018: Here are four stocks trading with heavy volume among 72 equities making new 52-week lows in Wednesday’s session. On the NYSE advancers led decliners by about 1.18 to 1 and on the Nasdaq, advancers led decliners by about 1.382 to 1.
VOD VOD VODPF AVEO HK AVP

12
Goodyear, Vodafone Slink into Tuesday’s 52-Week Low Club

2018-07-17 247wallst
July 17, 2018: Here are four stocks trading with heavy volume among 68 equities making new 52-week lows in Tuesday’s session. On the NYSE advancers led decliners by about 1.34 to 1 and on the Nasdaq, advancers led decliners by about 1.38 to 1.
GT VOD VOD VODPF HK AVP

30
46 Nasdaq 'Safer' Dividend Net Gains Led By Lam, Western, Broadcom, Vodafone, And KLA-Tencor, Per Broker July Targets

2018-07-17 seekingalpha
46 of 52 NASDAQ Index dividends were presumed "safer" because they showed positive one-year returns and free cash flow yields greater than dividend yields as of 7/12/17.
FOX LRCX VOD VOD GILD CMCSA WDC STX PCAR MCHP KLAC VODPF AVGO CSCO SBUX QCOM FOXA PAYX

34
Your 52 Top Yield, Upside, And Net Gain Nasdaq Stocks For July

2018-07-16 seekingalpha
"The Nasdaq-100 Index includes 100 of the largest domestic and international non-financial companies listed on The Nasdaq Stock Market based on market capitalization." 52 pay dividends.
LRCX VOD WYNN VOD GILD FAST CMCSA WDC STX PCAR MCHP KLAC VODPF AVGO KHC CSCO SBUX QCOM PAYX

34
Your 52 Top Yield, Upside, & Net Gain NASDAQ Stocks For July

2018-07-16 seekingalpha
"The Nasdaq-100 Index includes 100 of the largest domestic and international non-financial companies listed on The Nasdaq Stock Market based on market capitalization." 52 pay dividends.
LRCX VOD WYNN VOD GILD FAST CMCSA WDC STX PCAR MCHP KLAC VODPF AVGO KHC CSCO SBUX QCOM PAYX

1
Vodafone optimistic Idea merger will be completed by October, says CEO Vittorio Colao

2018-07-10 livemint
New Delhi: Vodafone Group Plc chief executive officer (CEO) Vittorio Colao has said on Tuesday that he is optimistic that the merger with Idea Cellular Ltd will be completed during his tenure.
532454 VOD VOD VODPF IDEA ICLQY 532822 BHRQY BHARTIARTL

17
Alibaba in Talks With BT for Cloud Partnership in Europe Push

2018-07-09 thestar.com.my
Alibaba Group Holding Ltd. is in talks with BT Group Plc about a cloud services partnership as the Chinese internet giant challenges Amazon.com Inc.’s dominance in Europe. An agreement between Alibaba and the IT consulting unit of Britain’s former phone monopoly could be similar to Alibaba’s existing arrangement with Vodafone Group Plc in Germany, according to a person familiar with the matter, who asked not to be identified as the talks are private.
BOLRF BT.A VOD VOD BTGOF GOOG DTEGF BT BABA VODPF GOOGL BOL CSCO MSFT DTEGY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 92857W100